Brief: Champions Oncology QTRLY Loss Per Share GAAP $0.06

Champions Oncology

26/07/2018 21:17

July 26 (Reuters) - Champions Biotechnology  Inc  CSBR.O :
    * CHAMPIONS ONCOLOGY REPORTS RECORD ANNUAL REVENUE EXCEEDING
$20M
FOR FISCAL YEAR ENDED APRIL 30, 2018
    * Q4 REVENUE ROSE 32.3 PERCENT TO $4.9 MILLION
    * CHAMPIONS BIOTECHNOLOGY  INC - QTRLY LOSS PER SHARE - GAAP
$0.06
    * CHAMPIONS BIOTECHNOLOGY  INC - QTRLY LOSS PER SHARE
NON-GAAP
$0.04

Source text for Eikon:  ID:nPn7ZV1psa 
Further company coverage:  CSBR.O 

 ((Reuters.Briefs@thomsonreuters.com;))